450,273 Shares in InfuSystem Holdings, Inc. $INFU Bought by Hillsdale Investment Management Inc.

Hillsdale Investment Management Inc. acquired a new position in shares of InfuSystem Holdings, Inc. (NYSE:INFU) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 450,273 shares of the company’s stock, valued at approximately $4,665,000.

Other large investors have also added to or reduced their stakes in the company. CWM LLC raised its holdings in InfuSystem by 1,160.1% in the second quarter. CWM LLC now owns 4,826 shares of the company’s stock worth $30,000 after buying an additional 4,443 shares during the last quarter. Raymond James Financial Inc. bought a new position in InfuSystem during the 2nd quarter valued at about $33,000. Jane Street Group LLC bought a new stake in shares of InfuSystem in the first quarter worth approximately $96,000. Bank of America Corp DE grew its position in InfuSystem by 19.4% in the 2nd quarter. Bank of America Corp DE now owns 17,994 shares of the company’s stock worth $112,000 after purchasing an additional 2,924 shares during the period. Finally, ARS Investment Partners LLC bought a new position in shares of InfuSystem during the 3rd quarter valued at $117,000. Hedge funds and other institutional investors own 71.13% of the company’s stock.

InfuSystem Price Performance

NYSE:INFU opened at $7.95 on Friday. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50. InfuSystem Holdings, Inc. has a 12 month low of $4.61 and a 12 month high of $11.04. The business’s 50-day moving average is $8.49 and its 200 day moving average is $9.31. The company has a market capitalization of $161.67 million, a P/E ratio of 132.52 and a beta of 1.67.

Analyst Upgrades and Downgrades

Separately, Roth Mkm reaffirmed a “buy” rating and set a $14.00 target price (up from $13.00) on shares of InfuSystem in a report on Tuesday, November 4th. Two investment analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $14.50.

InfuSystem Company Profile

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.